Integer (NYSE:ITGR) PT Raised to $140.00

Integer (NYSE:ITGR) had its target price boosted by analysts at Benchmark from $130.00 to $140.00 in a report released on Monday, Benzinga reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. Benchmark’s price target indicates a potential upside of 11.49% from the stock’s previous close.

Other equities research analysts also recently issued reports about the stock. KeyCorp upped their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 15th. Truist Financial upped their price objective on shares of Integer from $145.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Bank of America upped their price objective on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. Citigroup upped their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. Finally, Oppenheimer started coverage on shares of Integer in a research report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price objective for the company. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $140.14.

Integer Trading Down 1.7 %

NYSE:ITGR opened at $125.58 on Monday. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm has a 50-day moving average of $127.19 and a 200-day moving average of $120.82. The company has a market cap of $4.21 billion, a PE ratio of 43.45, a PEG ratio of 1.86 and a beta of 1.08. Integer has a one year low of $69.40 and a one year high of $133.53.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, topping the consensus estimate of $1.24 by $0.06. The company had revenue of $436.20 million during the quarter, compared to the consensus estimate of $437.00 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The firm’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.14 earnings per share. As a group, equities research analysts expect that Integer will post 5.3 EPS for the current fiscal year.

Insider Activity

In related news, Director Jean M. Hobby sold 11,960 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the sale, the director now directly owns 2,280 shares in the company, valued at approximately $272,824.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 2.00% of the company’s stock.

Institutional Trading of Integer

Several institutional investors and hedge funds have recently bought and sold shares of the company. OLD National Bancorp IN lifted its stake in Integer by 10.9% in the 3rd quarter. OLD National Bancorp IN now owns 2,375 shares of the medical equipment provider’s stock worth $309,000 after purchasing an additional 234 shares in the last quarter. Waypoint Capital Advisors LLC purchased a new stake in shares of Integer during the 3rd quarter valued at $246,000. Creative Planning raised its position in shares of Integer by 22.2% during the 3rd quarter. Creative Planning now owns 9,077 shares of the medical equipment provider’s stock valued at $1,180,000 after buying an additional 1,650 shares in the last quarter. Contravisory Investment Management Inc. raised its position in shares of Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 80 shares in the last quarter. Finally, High Note Wealth LLC raised its position in shares of Integer by 66.8% during the 3rd quarter. High Note Wealth LLC now owns 3,200 shares of the medical equipment provider’s stock valued at $416,000 after buying an additional 1,282 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.